Current Trials
Study Participation
& Current Trials
Allergy Research Canada is currently recruiting for studies in Atopic Dermatitis, Asthma, and Urticaria/Hives. If you qualify for study participation, financial compensation for your time and travel expenses will be provided.
Atopic Dermatitis
Nemolizumab
NCT03985943 Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis
Baricitinib
NCT03559270 A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Upadacitinib
NCT03607422 A Study to Evaluate Upadacitinib in Adolescent and Adult Subjects With Moderate to Severe Atopic Dermatitis
Baricitinib
NCT03435081 A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Chronic Spontaneous Urticaria
LOU064
NCT04109313 Open-label, Multicenter, Extension Study to Evaluate Long-term Safety and Tolerability of LOU064 in Subjects With CSU
LOU064
Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines
Psoriasis
NCT02786186
NCT02786186 A Registry of Patients With Moderate to Severe Plaque Psoriasis
Interested in participating in current or future trials?
Fill out our questionnaire to see if you qualify for a clinical trial or to be added to our database of patients interested in learning about clinical trials.